233 related articles for article (PubMed ID: 37174676)
21. Remedial strategies in structural proteomics: expression, purification, and crystallization of the Vav1/Rac1 complex.
Brooun A; Foster SA; Chrencik JE; Chien EY; Kolatkar AR; Streiff M; Ramage P; Widmer H; Weckbecker G; Kuhn P
Protein Expr Purif; 2007 May; 53(1):51-62. PubMed ID: 17275330
[TBL] [Abstract][Full Text] [Related]
22. Function of the nucleotide exchange activity of vav1 in T cell development and activation.
Saveliev A; Vanes L; Ksionda O; Rapley J; Smerdon SJ; Rittinger K; Tybulewicz VL
Sci Signal; 2009 Dec; 2(101):ra83. PubMed ID: 20009105
[TBL] [Abstract][Full Text] [Related]
23. The haematopoietic specific signal transducer Vav1 is aberrantly expressed in lung cancer and plays a role in tumourigenesis.
Lazer G; Idelchuk Y; Schapira V; Pikarsky E; Katzav S
J Pathol; 2009 Sep; 219(1):25-34. PubMed ID: 19533802
[TBL] [Abstract][Full Text] [Related]
24. Vav1 fine tunes p53 control of apoptosis versus proliferation in breast cancer.
Sebban S; Farago M; Gashai D; Ilan L; Pikarsky E; Ben-Porath I; Katzav S
PLoS One; 2013; 8(1):e54321. PubMed ID: 23342133
[TBL] [Abstract][Full Text] [Related]
25. Vav1 mutations identified in human cancers give rise to different oncogenic phenotypes.
Shalom B; Farago M; Pikarsky E; Katzav S
Oncogenesis; 2018 Oct; 7(10):80. PubMed ID: 30297765
[TBL] [Abstract][Full Text] [Related]
26. Guanine nucleotide exchange factor Vav1 regulates perivascular homing and bone marrow retention of hematopoietic stem and progenitor cells.
Sanchez-Aguilera A; Lee YJ; Lo Celso C; Ferraro F; Brumme K; Mondal S; Kim C; Dorrance A; Luo HR; Scadden DT; Williams DA
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9607-12. PubMed ID: 21606370
[TBL] [Abstract][Full Text] [Related]
27. The N-terminal 20-amino acid region of guanine nucleotide exchange factor Vav1 plays a distinguished role in T cell receptor-mediated calcium signaling.
Li SY; Du MJ; Wan YJ; Lan B; Liu YH; Yang Y; Zhang CZ; Cao Y
J Biol Chem; 2013 Feb; 288(6):3777-85. PubMed ID: 23271736
[TBL] [Abstract][Full Text] [Related]
28. The fusion oncogene VAV1-MYO1F triggers aberrant T-cell receptor signaling in vivo and drives peripheral T-cell lymphoma in mice.
Morrish E; Wartewig T; Kratzert A; Rosenbaum M; Steiger K; Ruland J
Eur J Immunol; 2023 Mar; 53(3):e2250147. PubMed ID: 36541400
[TBL] [Abstract][Full Text] [Related]
29. Vav1 promotes lung cancer growth by instigating tumor-microenvironment cross-talk via growth factor secretion.
Sebban S; Farago M; Rabinovich S; Lazer G; Idelchuck Y; Ilan L; Pikarsky E; Katzav S
Oncotarget; 2014 Oct; 5(19):9214-26. PubMed ID: 25313137
[TBL] [Abstract][Full Text] [Related]
30. Cancer-associated mutations in VAV1 trigger variegated signaling outputs and T-cell lymphomagenesis.
Robles-Valero J; Fernández-Nevado L; Lorenzo-Martín LF; Cuadrado M; Fernández-Pisonero I; Rodríguez-Fdez S; Astorga-Simón EN; Abad A; Caloto R; Bustelo XR
EMBO J; 2021 Nov; 40(22):e108125. PubMed ID: 34617326
[TBL] [Abstract][Full Text] [Related]
31. Vav1-mediated scaffolding interactions stabilize SLP-76 microclusters and contribute to antigen-dependent T cell responses.
Sylvain NR; Nguyen K; Bunnell SC
Sci Signal; 2011 Mar; 4(163):ra14. PubMed ID: 21386095
[TBL] [Abstract][Full Text] [Related]
32. Vav1 and Ly-GDI two regulators of Rho GTPases, function cooperatively as signal transducers in T cell antigen receptor-induced pathways.
Groysman M; Hornstein I; Alcover A; Katzav S
J Biol Chem; 2002 Dec; 277(51):50121-30. PubMed ID: 12386169
[TBL] [Abstract][Full Text] [Related]
33. The use of knockout mice reveals a synergistic role of the Vav1 and Rasgrf2 gene deficiencies in lymphomagenesis and metastasis.
Ruiz S; Santos E; Bustelo XR
PLoS One; 2009 Dec; 4(12):e8229. PubMed ID: 20011522
[TBL] [Abstract][Full Text] [Related]
34. Phosphatidylinositol Monophosphates Regulate Optimal Vav1 Signaling Output.
Rodríguez-Fdez S; Citterio C; Lorenzo-Martín LF; Baltanás-Copado J; Llorente-González C; Corbalán-García S; Vicente-Manzanares M; Bustelo XR
Cells; 2019 Dec; 8(12):. PubMed ID: 31888228
[TBL] [Abstract][Full Text] [Related]
35. Vav1 as a central regulator of invadopodia assembly.
Razidlo GL; Schroeder B; Chen J; Billadeau DD; McNiven MA
Curr Biol; 2014 Jan; 24(1):86-93. PubMed ID: 24332539
[TBL] [Abstract][Full Text] [Related]
36. Vav1 regulates MHCII expression in murine resting and activated B cells.
Jux B; Staratschek-Jox A; Penninger JM; Schultze JL; Kolanus W
Int Immunol; 2013 May; 25(5):307-17. PubMed ID: 23391492
[TBL] [Abstract][Full Text] [Related]
37. Ectopic expression of VAV1 reveals an unexpected role in pancreatic cancer tumorigenesis.
Fernandez-Zapico ME; Gonzalez-Paz NC; Weiss E; Savoy DN; Molina JR; Fonseca R; Smyrk TC; Chari ST; Urrutia R; Billadeau DD
Cancer Cell; 2005 Jan; 7(1):39-49. PubMed ID: 15652748
[TBL] [Abstract][Full Text] [Related]
38. Regulatory interplay between Vav1, Syk and β-catenin occurs in lung cancer cells.
Boudria R; Laurienté V; Oudar A; Harouna-Rachidi S; Dondi E; Le Roy C; Gardano L; Varin-Blank N; Guittat L
Cell Signal; 2021 Oct; 86():110079. PubMed ID: 34252536
[TBL] [Abstract][Full Text] [Related]
39. Mechanism and function of Vav1 localisation in TCR signalling.
Ksionda O; Saveliev A; Köchl R; Rapley J; Faroudi M; Smith-Garvin JE; Wülfing C; Rittinger K; Carter T; Tybulewicz VL
J Cell Sci; 2012 Nov; 125(Pt 22):5302-14. PubMed ID: 22956543
[TBL] [Abstract][Full Text] [Related]
40. [Regulatory effect of Vav1 on T cells and its relation to clinical diseases].
Zhang Y; Chen W
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):75-81. PubMed ID: 30146815
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
